Evidence from real-world studies and a 2024 survey revealed that the use of doxycycline as postexposure prophylaxis (PEP) for sexually transmitted infections (STIs) in Spain is expanding beyond ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results